Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

India's drug regulatory body, CDSCO, has banned 35 fixed-dose combination drugs, including painkillers and anti-diabetics, ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Eli Lilly's new oral weight loss pill, orforglipron, shows promise in Phase 3 trials, offering a convenient alternative to ...

US food tech startup Perfect Day has been hit with a false marketing lawsuit for its FDA-approved, animal-free dairy whey ...

Color additives have faced increased scrutiny since the FDA banned Red Dye No. 3, citing concerns over its links to cancer.

Bausch Health Companies (BHC) and its gastroenterology business, Salix Pharmaceuticals, announced the U.S. District Court for the District of ...

Another roadblock, Santa Clara County prosecutors say, is what they describe as the complicated process for referring a Prop ...